SCHEMBL4462447

SCHEMBL4462447

NC(=O)CNCCc1cccnc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.54
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CHRNA7 P36544 1/20 0.50
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
TBXAS1 P24557 7/20 0.49
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP2A6 P11509 1/20 0.47
NAPRT Q6XQN6 1/20 0.47
CYP2D6 P10635 1/20 0.47
FDPS P14324 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25179537 0.86 TBXAS1 (0.62) CYP1A2CYP3A4CYP2C9HDAC2HDAC8
SCHEMBL12831688 0.84 HDAC2 (0.49) RECQLCYP1A2CYP3A4CYP2C9CHRNA7
SCHEMBL3394144 0.84 CYP1A2 (0.51) RECQLCYP1A2CYP3A4CYP2C9HDAC2
SCHEMBL29644833 0.84 RECQL (0.66) RECQLCYP1A2CYP3A4CYP2C9KMT2A
SCHEMBL1815219 0.84 RECQL (0.66) RECQLCYP1A2CYP3A4CYP2C9KMT2A
SCHEMBL16606311 0.81 CYP1A2 (0.63) CYP1A2CHRNA7HDAC2HDAC8HDAC6
SCHEMBL2755854 0.81 RECQL (0.71) RECQLCYP1A2CYP3A4CYP2C9CHRNA7
SCHEMBL4344215 0.80 TAAR1 (0.54) CYP1A2CYP3A4CYP2C9HDAC2NPC1
SCHEMBL29644853 0.79 SMN1; SMN2 (0.52) CYP1A2CYP3A4CYP2C9HDAC2HDAC8
SCHEMBL83186 0.78 RECQL (0.62) RECQLCYP1A2CYP3A4CYP2C9CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO claimed